Index Ventures Commits $13.8M to Mind-NRG

Swiss start-up Mind-NRG has raised 1.5 million Euro ($2 million) from Index Ventures. The initial investment is part of a total 10 million Euro ($13.8 million) in funding that Index has allocated to the newly incorporated company. Mind-NRG develops drugs for neurological and psychiatric disorders. Index Ventures has offices in Geneva, London and in St. Helier, Jersey.

North AmericaUSBriefs